Cipla Names Arun Kakatkar as Global Chief People Officer

Prior to joining Cipla, Kakatkar has held senior leadership positions with several reputed global organisations, including Microsoft Corporation, Kalyani Group, and TE Connectivity India.

Written By :  Parthika Patel
Published On 2026-02-02 11:37 GMT   |   Update On 2026-02-02 11:37 GMT
Advertisement

New Delhi: Drug major Cipla Limited has approved the appointment of Arun Kakatkar as its Global Chief People Officer (GCPO) and Senior Management Personnel, with effect from March 17, 2026, according to a regulatory disclosure by the company.

The decision was taken by the Board of Directors at its meeting held on February 2, 2026, and has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Cipla stated that the appointment is in line with the applicable SEBI Listing Regulations and the relevant master circular issued in November 2024.

Advertisement

As per the disclosure, Arun Kakatkar will be appointed on a full-time employment basis and will be part of Cipla’s senior management team. In his new role, he will be responsible for leading the company’s global people strategy, organisational development, leadership capability, and culture initiatives across geographies.

Cipla described Kakatkar as a seasoned business leader with extensive experience across multiple business functions, industries, and international markets. He has led diverse teams in global environments and has been credited with delivering transformational outcomes in large organisations.

Prior to joining Cipla, Kakatkar has held senior leadership positions with several reputed global organisations, including Microsoft Corporation, Kalyani Group, and TE Connectivity India. He holds an engineering degree and an MBA from Pune University, and is deeply focused on building strong organisational culture, developing leadership talent, and enabling sustainable business outcomes.

The company further clarified that there is no relationship between the appointee and any of the directors of Cipla, as required under the SEBI Listing Regulations.

Also Read: Cipla Reappoints P R Ramesh as Independent Director for Second Term Till 2031

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News